Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes

Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes

To compare the glucose response in tube fed subjects with type 2 diabetes of a standard enteral product to that of a diabetes-specific enteral product

Inclusion Criteria:

• signed and dated informed consent
• diagnosis of type 2 diabetes
• HbA1c between 7.0 and 9.0%
• 18 - 75 years of age
• currently receiving a standard enteral product
• anticipated duration on tube feeding at least one month
• 100% of patient's nutrient and energy needs are anticipated to be met by enteral nutrition support
• anticipated life expectancy is more than or equal to 6 months
• free of infections
• no change in medications within 2 weeks prior to screening that could profoundly affect blood glucose

Exclusion Criteria:

• composition of either product is inappropriate for the patient due to allergies or intolerance to any ingredient found in the study products
• composition of either product is inappropriate for the patient due to protein, fluid or electrolyte restrictions for concomitant conditions
• significant cardiovascular event less than or equal to 2 weeks prior to study entry
• major surgery less than or equal to 2 weeks prior to study entry
• pre-planned surgery during the study period
• active malignancy, including melanoma and excluding cutaneous malignancies
• severe dementia
• known allergies to medical grade adhesives and/or skin disinfectants
• taking octreotide
• chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV
• participation in a concomitant trial